Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Granulocyte Colony-Stimulating Factor × Breast × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 15 Lymphoid 12 Myeloid 7 Plasma cell 2 Sarcoma 1 Classical hematology 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Letrozole 39 Paclitaxel 37 Fulvestrant 37 Specimen Handling 32 pembrolizumab 31 Magnetic Resonance Spectroscopy 29 Trastuzumab 27 Capecitabine 22 Anastrozole 22 ribociclib 21 Biopsy 21 exemestane 19 Tamoxifen 18 Carboplatin 18 Cyclophosphamide 16 trastuzumab deruxtecan 15 pertuzumab 15 palbociclib 14 abemaciclib 14 Docetaxel 14 130-nm albumin-bound paclitaxel 14 Blood Specimen Collection 13 Taxes 12 Radiotherapy 12 olaparib 11 Doxorubicin 11 inavolisib 10 eribulin 9 X-Rays 9 tucatinib 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05296317 2026-02-19

EMEG-ECDD

Centre Georges Francois Leclerc

Phase NA Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡